Recurrent R-spondin fusions in colon cancerSomasekar Seshagiri, Frédéric J. de Sauvage|Nature|2012Cited by 973
Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypesSteffen Durinck, Somasekar Seshagiri, Ying‐Jiun Chen et al.|Nature Genetics|2014Cited by 359
Combined Targeting of BRAF and CRAF or BRAF and PI3K Effector Pathways Is Required for Efficacy in NRAS Mutant TumorsBijay S. Jaiswal, Somasekar Seshagiri|PLoS ONE|2009Cited by 108
Conditional activation of Pik3caH1047R in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutationsWenlin Yuan, Somasekar Seshagiri|Oncogene|2012Cited by 73
Regulation of ERK3/MAPK6 expression by BRAFKlaus P. Hoeflich, Somasekar Seshagiri|International Journal of Oncology|2006Cited by 32